文献速递免疫规划卫生政策与健康促进

公众对鼻内和超声介导疫苗递送的态度:英国与美国横断面研究

Public attitudes towards intranasal and ultrasound mediated vaccine delivery: A cross-sectional study in the United Kingdom and United States.
PubMed 文献 · Vaccine · 2025-11-11

该研究对比英国(n=491)与美国(n=500)成年人群对鼻喷雾和超声经皮两种无针疫苗接种平台相较传统针筒注射的偏好。超声的OBSRVT均分最高(英国47.98,美国47.41),均超过针筒注射等效阈值45;受访者愿为超声支付25%(英国)和27%(美国)溢价。结论认为超声介导接种优于鼻喷雾和针筒注射,尤其在针头与疫苗犹豫人群中。

要点

  • 超声经皮接种OBSRVT均分英国47.98、美国47.41,均高于针筒注射等效阈值45。
  • 相对针筒注射,受访者愿为超声支付英国25%、美国27%溢价,鼻喷雾仅4%和8%。
  • 价格每增加25英镑/美元,选择鼻喷雾的几率降低30-40%,超声仅降低11-35%。

核心结论

  • 超声介导接种相较鼻喷雾和针筒注射更受偏好,在针头与疫苗犹豫人群中尤为明显。

研究设计与样本

  • 在英国(n=491)和美国(n=500)开展具有人口学代表性的在线小组横断面研究,使用OBSRVT、ONE量表、OVHS、支付意愿、陈述偏好和两项二元离散选择实验(DCE)进行评估。

主要发现

  • OBSRVT均分超声最高(英国47.98[95%CI 47.07, 48.88];美国47.41[95%CI 46.35, 48.48]),均超过针筒注射等效阈值45。
  • 相对针筒注射,超声支付溢价英国25%、美国27%;鼻喷雾支付溢价英国4%、美国8%。
  • DCE中价格每增加25英镑/美元,选择鼻喷雾的几率降低30-40%,选择超声的几率仅降低11-35%。
  • ONE量表四分位和OVHS疼痛亚量表四分位升高与OBSRVT评分升高及鼻喷雾和超声支付意愿升高相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Needle fear and vaccine hesitancy remain important barriers to widespread vaccination. We compared public preferences for two needle-free delivery platforms-nasal spray and high-intensity focused ultrasound transdermal vaccination-against conventional needle-and-syringe (N&S) administration. METHODS: Demographically representative online panels of adults in the United Kingdom (UK; n = 491) and United States (US; n = 500) completed multiple validated instruments: the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT, primary outcome measure), Oxford Needle Experience (ONE) scale and Oxford Vaccine Hesitancy Scale (OVHS). Preferences were assessed using the OBSRVT, stated willingness-to-pay (WTP), stated preferences, and two binary discrete-choice experiments (DCEs). Associations with needle and vaccine hesitancy were analyzed using the ONE scale and OVHS for quartile stratification with Cuzick's test for trend. RESULTS: Mean OBSRVT scores exceeded the N&S equivalence threshold (45) for both alternatives, with ultrasound highest (UK: 47.98 [95 % CI 47.07, 48.88]; US: 47.41 [95 % CI 46.35, 48.48]). Respondents were willing to pay a 25 % (UK) and 27 % (US) premium for ultrasound relative to N&S; corresponding premiums for nasal spray were 4 % and 8 %. In DCEs, each £/$25 price increase reduced the odds of choosing nasal spray by 30-40 %, but only 11-35 % for ultrasound, indicating lower price sensitivity for ultrasound. Increasing ONE scale quartile and OVHS pain subscale quartile were associated with increasing OBSRVT score and increasing WTP for nasal spray and ultrasound. CONCLUSIONS: Ultrasound-mediated vaccination is preferred over both nasal spray and N&S, particularly among needle- and vaccine-hesitant individuals. Needle-free technologies hold promise for improving uptake while streamlining logistics. This approach offers a transferable framework for de-risking emerging vaccine delivery platforms.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kantor J, Morrison M, Vanderslott S, et al. Public attitudes towards intranasal and ultrasound mediated vaccine delivery: A cross-sectional study in the United Kingdom and United States. Vaccine. 2025. PMID: 41223692. doi:10.1016/j.vaccine.2025.127950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。